We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Earlier Tracheostomies May Benefit COVID-19 Patients

By HospiMedica International staff writers
Posted on 21 Jan 2021
A new study suggests that in SARS-CoV-2 infected patients, a tracheostomy seven to 14 days after initiation of ventilation has better outcomes than waiting another week. More...


Researchers at NYU Langone Medical Center (New York, NY, USA) and New York University (NYU, USA) conducted a retrospective review of records of 148 patients with COVID-19 requiring mechanical ventilation between March 1 and May 7, 2020, in order to assess the impact of early tracheostomy in airway management. Outcomes were time from symptom onset to endotracheal intubation; time from endotracheal intubation to tracheostomy; time from tracheostomy to tube downsizing and decannulation; total time on mechanical ventilation; and total length of stay.

The results showed that for the early tracheostomy group, mean time to tracheostomy was 17.38 days from symptom onset and 5.8 days from intubation. For the late tracheostomy group, the mean time to tracheotomy was 25.69 days from symptom onset and 15.83 days from intubation. The mean time for discontinuing ventilation from intubation was 26.5 days for the early group and 31 days for the late group. In a model with death as the main risk outcome, the late tracheostomy group was 16% less likely to discontinue mechanical ventilation. The study was published on December 17, 2020, in JAMA Otolaryngology-Head & Neck Surgery.

“Early in the pandemic, guidelines based on expert opinion suggested delaying tracheostomy to protect providers. Our concern was that waiting two to three weeks really does predispose patients to airway narrowing and vocal cord paralysis,” said lead author Paul Kwak, MD, of NYU School of Medicine. “Our study demonstrated non-inferiority of early tracheostomy. We saw no increase in infections in surgeons or providers, and this demonstrated the long-term outcomes of these patients indeed were comparable to the late group, with some measures in which the early patients did better.”

A tracheostomy is a procedure that that creates a stoma on the anterior aspect of the neck, opening a direct airway through the incision in the trachea. A tracheostomy tube is then placed into the opening to provide an air passage when the larynx is blocked or reduced. A tracheostomy is often needed when long-term machine ventilation is required; when no longer needed, it is allowed to heal or is surgically closed.

Related Links:
NYU Langone Medical Center
New York University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.